Outcome for patients with leukemia, multiple myeloma and lymphoma who relapse after high dose therapy and autologous stem cell support

Johnsen, H E (author)

Bjorkstrand, B (author)

Carlson, K (author)

Uppsala universitet,Institutionen för medicinska vetenskaper

show more...

Gruber, A (author)

Blystad, A (author)

Fast, A (author)

Boesen, A M (author)

Bjorkholm, M (author)

Sallerfors, B (author)

Ruutu, T (author)

Carneskog, J (author)

Malm, A (author)

Geisler, C (author)

Lehtinen, M (author)

Schroder, H (author)

Brinch, L (author)

Remes, K (author)

Tidefelt, U (author)

Heilman, C (author)

Hornsten, P (author)

Thorling, K (author)

Daugaard, G (author)

show less...

 (creator_code:org_t)

1996

1996

English.

In: Leukemia and Lymphoma. ; 24, s. 81-

Related links:

https://urn.kb.se/re...

• Journal article (peer-reviewed)